Henry Schein logo

Henry Schein(NASDAQ) HSIC

Market Cap$9.63BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)+1,837%
5 Year+7%
1 Year+33%
1 Month-1%
Premium Feature
Moneyball Superscore
64/100
$83.98
-2.78%
-2.40Today
After hours$83.97-$0.01 (-0.01%)
Henry Schein last closing stock price
MetricPriceDate
Last closeUSD 83.972026-10-19
Henry Schein stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.31%USD 84.232026-10-12
1 month-1.03%USD 84.842026-09-18
3 month-2.2%USD 85.862026-07-21
Year to date+11.1%USD 75.582025-12-31
1 year+33.33%USD 62.982025-10-17
3 year+22.92%USD 68.312023-10-20
5 year+7.01%USD 78.472021-10-20
Since inception+1,837.42%USD 4.461995-11-03

Henry Schein Financials at a Glance

Market Cap

$9.63BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$13.60B

Net Income (TTM)

$403.00M

EPS (TTM)

$3.43

P/E Ratio

25.17

Dividend

$0.00

Beta (Volatility)

0.60 (Low)

Price

$83.98

Volume

1,317,231.79

Open

$86.32

Previous Close

$83.97

Daily Range

$83.92 - $87.36

52-Week Range

$62.15 - $92.18

Estimated Earnings Date

Nov 3, 2026

HSIC: Motley Fool Moneyball Superscore

64

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Henry Schein

Henry Schein, Inc. NASDAQ:HSIC helps dentists and doctors get supplies for their offices. It provides tools like dental chairs and medicine to 1 million customers. It also makes software that helps doctors run their businesses.

What’s on the Menu?

  • Global Dental: Supplies consumable merchandise such as infection control items and dental chairs; accounts for 53.6% of net sales in the three months ended June 27, 2026.
  • Global Medical: Distributes medicine, vaccines, and surgical tools to physician practices and clinics; represented 30.6% of net sales in the three months ended June 27, 2026.
  • Global Specialty Products: Manufactures dental implants and orthodontic supplies; contributed 12.1% of net sales in the three months ended June 27, 2026.
  • Global Technology: Provides practice management software and digital services to help offices stay organized; accounted for 5.2% of net sales in the three months ended June 27, 2026.

Moves to Expand the Reach

  • Committed to a restructuring plan on Aug. 6, 2024, to integrate acquisitions and increase efficiencies.
  • Entered a strategic partnership agreement with KKR in January 2025.
  • Appointed Frederick M. Lowery as the new chief executive officer effective March 2, 2026.
  • Executed a $250 million accelerated share repurchase program in May 2025.

A Global Support Network

The company operates a global network with locations in 34 countries and territories to reach 1 million customers. Its One Schein initiative combines supply chain services, equipment sales, and software into a single program for medical practices.

Performance by the Numbers

  • Net sales were $3.5 billion in the three months ended June 27, 2026, up 6.7% year over year.
  • Gross profit reached $1.1 billion for the three-month period ended June 27, 2026, up 8.3% year over year.
  • Global Technology sales rose 8.2% to $181 million during the three months ended June 27, 2026.
  • Net cash provided by operating activities was $145 million for the six months ended June 27, 2026.

The Evolution of the Business

Henry Schein has transitioned from a traditional distributor to a comprehensive solutions provider for healthcare professionals. This evolution includes expanding into high-margin specialty manufacturing and digital practice management tools.

AI Generated • Aug 5, 2026

Industry

Healthcare Providers and Services

Employees

25,000

CEO

Frederick M. Lowery

Headquarters

Melville, NY 11747, US

HSIC Financials

Key Financial Metrics (TTM)

Gross Margin

30.31%

Operating Margin

5.69%

Net Income Margin

2.96%

Return on Equity

12.37%

Return on Capital

10.93%

Return on Assets

3.54%

Earnings Yield

3.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.63BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

111.45M

Volume

1.32M

Avg. Volume

1.19M

Financials (TTM)

Gross Profit

$4.12B

Operating Income

$774.00M

EBITDA

$1.05B

Operating Cash Flow

$700.00M

Capital Expenditure

-$161.00M

Free Cash Flow

$539.00M

Cash & ST Invst.

$157.00M

Total Debt

$3.81B

Henry Schein Performance Analysis

Henry Schein annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 12,647,000,0002.0%
20232023-12-31USD 12,339,000,000-2.4%
20242024-12-31USD 12,673,000,0002.7%
20252025-12-31USD 13,184,000,0004.0%
Henry Schein sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-273.1%
Q42025-12-272.9%
Q12026-03-28-2.0%
Q22026-06-272.7%
Henry Schein annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 3.91-11.3%
20232023-12-31USD 3.16-19.2%
20242024-12-31USD 3.05-3.3%
20252025-12-31USD 3.277.1%
Henry Schein sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-2720.0%
Q42025-12-271.2%
Q12026-03-288.2%
Q22026-06-27-10.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$3.46B

+6.7%

Gross Profit

$1.10B

+15.7%

Gross Margin

31.84%

N/A

Market Cap

$9.63BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$385.07K

N/A

Employees

25,000

N/A

Net Income

$94.00M

+9.3%

EBITDA

$264.00M

+12.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$157.00M

+8.3%

Total Debt

$3.81B

+13.5%

Accounts Receivable

$1.76B

+7.2%

Inventory

$2.06B

+7.9%

Long Term Debt

$2.58B

+9.6%

Short Term Debt

$1.24B

+22.7%

Return on Assets

3.54%

N/A

Return on Invested Capital

9.81%

N/A

Free Cash Flow

$196.00M

+122.7%

Operating Cash Flow

$242.00M

+101.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVSTEnvista Holdings Corp
$22.61-1.27%
XRAYDENTSPLY SIRONA Inc.
$8.42-1.75%
ACHAccendra Health, Inc.
$0.22-6.30%
CAHCardinal Health, Inc.
$252.65-0.55%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.03+2.43%
CRWVCoreWeave
$61.12-0.44%
NVDANvidia
$217.09+1.38%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$98.65+5.32%

Questions About HSIC

What is the current price of Henry Schein?

Henry Schein is trading at $83.97 per share.

What is the 52-week range for Henry Schein?

Over the past 52 weeks, Henry Schein has traded between $62.15 and $92.18.

How much debt does Henry Schein have?

As of the most recent reporting period, Henry Schein reported total debt of $3.81B.

How much cash does Henry Schein have on hand?

Henry Schein reported $157.00M in cash and cash equivalents in its most recent financial results.

What is Henry Schein’s dividend yield?

Henry Schein does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.